Endocrinology, Vol 137, 991-999, Copyright © 1996 by Endocrine Society

ARTICLES

Transforming growth factor-beta1 is a mediator of androgen-regulated growth arrest in an androgen-responsive prostatic cancer cell line, LNCaP

IY Kim, JH Kim, DJ Zelner, HJ Ahn, JA Sensibar and C Lee
Department of Urology, Northwestern University Medical School, Chicago, Illinois 60611, USA.

LNCaP is an androgen-responsive prostatic cancer cell line that exhibits a bell-shaped growth response to increasing doses of dihydrotestosterone (DHT) in culture. Although the precise mechanism responsible for this growth response to androgen stimulation remains unclear, many studies have suggested that androgen modulates the level of various growth factors. In the present study, the role of transforming growth factor-beta (TGF-beta) in mediating the androgen- regulated growth arrest of LNCaP cells was investigated. The following concentrations of DHT were used: 0, 10(-12), 10(-10), and 10 (-7) M. These concentrations were selected because they represent the zero DHT control, the low-proliferative dose, the high-proliferative dose, and the growth arrest dose, respectively. Results of RT-PCR showed that LNCaP cells express TGF-beta1 but not -beta2 and -beta3 messenger RNA. Competitive quantitative RT-PCR demonstrated that the level of TGF- beta1 messenger RNA increased approximately 7-fold when cells were treated with 10(-7) M DHT. Results of Western blot analysis showed a dramatic increase in the level of latent TGF-beta1 protein in cell lysates with increasing concentrations of DHT. In addition, results of enzyme-linked immunoadsorbent assay for TGF-beta1 indicated that treatment of LNCaP cells with DHT led to a dose-dependent increase in both total and biologically active TGF-beta1 in the conditioned media. To determine the role of TGF-beta1 in regulating LNCaP proliferation, the action of TGF-beta1 was blocked by two different but complementary approaches. First, TGF-beta1 neutralizing antibody was added to the culture medium with varying concentrations of DHT. Second, mannose-6- phosphate, which has been demonstrated to inhibit the activation of latent TGF-beta1, was added in a similar manner to the culture. Results demonstrated that the characteristic bell- shaped growth response following treatment with increasing doses of DHT was converted to a linear dose-response curve as the growth of inhibition seen at the high dose by DHT was abolished. These observations, taken together, indicate that TGF-beta1 mediates at least in part the growth arrest observed at the high concentration of DHT in LNCaP cells.

This article has been cited by other articles:

				J. K. Hess-Wilson, H. K. Daly, W. A. Zagorski, C. P. Montville, and K. E. Knudsen Mitogenic Action of the Androgen Receptor Sensitizes Prostate Cancer Cells to Taxane-Based Cytotoxic Insult Cancer Res., December 15, 2006; 66(24): 11998 - 12008. [Abstract] [Full Text] [PDF]

				Y. Xu, S.-Y. Chen, K. N. Ross, and S. P. Balk Androgens Induce Prostate Cancer Cell Proliferation through Mammalian Target of Rapamycin Activation and Post-transcriptional Increases in Cyclin D Proteins. Cancer Res., August 1, 2006; 66(15): 7783 - 7792. [Abstract] [Full Text] [PDF]

				T.E. Hickey, D.L. Marrocco, F. Amato, L.J. Ritter, R.J. Norman, R.B. Gilchrist, and D.T. Armstrong Androgens Augment the Mitogenic Effects of Oocyte-Secreted Factors and Growth Differentiation Factor 9 on Porcine Granulosa Cells Biol Reprod, October 1, 2005; 73(4): 825 - 832. [Abstract] [Full Text] [PDF]

				Q. Zhang, J. N. Rubenstein, T. L. Jang, M. Pins, B. Javonovic, X. Yang, S.-J. Kim, I. Park, and C. Lee Insensitivity to Transforming Growth Factor-{beta} Results from Promoter Methylation of Cognate Receptors in Human Prostate Cancer Cells (LNCaP) Mol. Endocrinol., September 1, 2005; 19(9): 2390 - 2399. [Abstract] [Full Text] [PDF]

				K. A. Link, C. J. Burd, E. Williams, T. Marshall, G. Rosson, E. Henry, B. Weissman, and K. E. Knudsen BAF57 Governs Androgen Receptor Action and Androgen-Dependent Proliferation through SWI/SNF Mol. Cell. Biol., March 15, 2005; 25(6): 2200 - 2215. [Abstract] [Full Text] [PDF]

				Y. B. Wetherill, N. L. Fisher, A. Staubach, M. Danielsen, R. W. de Vere White, and K. E. Knudsen Xenoestrogen Action in Prostate Cancer: Pleiotropic Effects Dependent on Androgen Receptor Status Cancer Res., January 1, 2005; 65(1): 54 - 65. [Abstract] [Full Text] [PDF]

				Y. B. Wetherill, C. E. Petre, K. R. Monk, A. Puga, and K. E. Knudsen The Xenoestrogen Bisphenol A Induces Inappropriate Androgen Receptor Activation and Mitogenesis in Prostatic Adenocarcinoma Cells Mol. Cancer Ther., May 1, 2002; 1(7): 515 - 524. [Abstract] [Full Text] [PDF]

				M. E. Taplin and S.-M. Ho The Endocrinology of Prostate Cancer J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3467 - 3477. [Full Text] [PDF]

				M. C. Zatelli, R. Rossi, and E. C. degli Uberti Androgen Influences Transforming Growth Factor-{beta}1 Gene Expression in Human Adrenocortical Cells J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 847 - 852. [Abstract] [Full Text]

				A. J. Sakko, C. Ricciardelli, K. Mayne, W. D. Tilley, R. G. LeBaron, and D. J. Horsfall Versican Accumulation in Human Prostatic Fibroblast Cultures Is Enhanced by Prostate Cancer Cell-derived Transforming Growth Factor {beta}1 Cancer Res., February 1, 2000; 61(3): 926 - 930. [Abstract] [Full Text]

				B. Loras, F. Vetele, A. E. Malki, J. Rollet, J.-C. Soufir, and M. Benahmed Seminal transforming growth factor-ß in normal and infertile men Hum. Reprod., June 1, 1999; 14(6): 1534 - 1539. [Abstract] [Full Text] [PDF]

				J. M. Kokontis, N. Hay, and S. Liao Progression of LNCaP Prostate Tumor Cells during Androgen Deprivation: Hormone-Independent Growth, Repression of Proliferation by Androgen, and Role for p27Kip1 in Androgen-Induced Cell Cycle Arrest Mol. Endocrinol., July 1, 1998; 12(7): 941 - 953. [Abstract] [Full Text]

				C. B. J. M. Cleutjens, K. Steketee, C. C. E. M. van Eekelen, J. A. G. M. van der Korput, A. O. Brinkmann, and J. Trapman Both Androgen Receptor and Glucocorticoid Receptor Are Able to Induce Prostate-Specific Antigen Expression, but Differ in Their Growth-Stimulating Properties of LNCaP Cells Endocrinology, December 1, 1997; 138(12): 5293 - 5300. [Abstract] [Full Text] [PDF]

				J. Szelei, J. Jimenez, A. M. Soto, M. F. Luizzi, and C. Sonnenschein Androgen-Induced Inhibition of Proliferation in Human Breast Cancer MCF7 Cells Transfected with Androgen Receptor Endocrinology, April 1, 1997; 138(4): 1406 - 1412. [Abstract] [Full Text] [PDF]